NCT00102349
Completed
Phase 3
HIV and HCV Intervention in Drug Treatment Settings
ConditionsBehavior Therapy
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Behavior Therapy
- Sponsor
- University of Colorado, Denver
- Enrollment
- 706
- Locations
- 8
- Primary Endpoint
- HIV/HCV injection risk behaviors
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
HIV/HCV injection risk behaviors
Study Sites (8)
Loading locations...
Similar Trials
Recruiting
N/A
Comprehensive HIV and Harm Prevention Via TelehealthHIV InfectionsNCT05897099University of Miami350
Terminated
Phase 1
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With HyperlipidemiaHIV InfectionsHyperlipidemiaNCT00663234International Maternal Pediatric Adolescent AIDS Clinical Trials Group28
Completed
N/A
HIV and Hepatitis Care Coordination in Methadone TreatmentHepatitis, Viral, HumanHIV InfectionsNCT00608192University of California, San Francisco489
Completed
Phase 2
Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral ReservoirHIV InfectionNCT00976404Robert L. Murphy28
Active, Not Recruiting
N/A
Tele-Harm ReductionIV Drug UsageHIV InfectionsHepatitis CNCT05208697University of Miami100